Preferred Label : Troglitazone;
MeSH definition : A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED
RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES
MELLITUS, but has been withdrawn due to hepatotoxicity.;
MeSH synonym : 5-(4-((6-Hydroxy-2,5,7,8-tetramethylchroman-2-yl-methoxy)benzyl)-2,4-thiazolidinedione)
- T;
MeSH hyponym : CS-045; CS045;
MeSH CAS label : 2,4-Thiazolidinedione, 5-((4-((3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy)phenyl)methyl)-;
MeSH Related Number : 97322-87-7 (Troglitazone);
UNII : I66ZZ0ZN0E;
Origin ID : D000077288;
UMLS CUI : C0245514;
- ATC code(s)
- Allowable qualifiers
- Automatic exact mappings (from CISMeF team)
- MeSH indexing information
- Pharmacological action(s)
- Record concept(s)
- Related MeSH Supplementary Concept(s)
- See also inter- (CISMeF)
- Semantic type(s)
- UMLS correspondences (same concept)
- Validated automatic mappings to BTNT
A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED
RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES
MELLITUS, but has been withdrawn due to hepatotoxicity.
https://www.cadth.ca/sites/default/files/pdf/ews1_cetap_f.pdf
1997
Canada
drug evaluation
diabetes mellitus, type 2
Troglitazone
---